State-of-the-Art Cardiovascular Medicine in Asia 2021
Submission Deadline: 1 Jan 2022
Guest Editors
Faculty of Medicine, Macau University of Science and Technology, Taipa, Macau, China
Interests: the pathogenesis and treatment of hyperlipidaemia; hypertension; the metabolic syndrome and diabetes the clinical pharmacology; toxicology and pharmacogenetics of drugs; particularly in the cardiovascular field
Special Issues in IMR Press journals
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
Interests: sleep apnea; sleep disorders; heart failure; hemodynamics; positive airway pressure; telemedicine
Special Issue in IMR Press journals
Special Issue in Perioperative Management in Cardiac Surgery
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a comprehensive overview of state-of-the-art of Cardiovascular Medicine in Asia. We invite research papers that will consolidate our understanding in this area. The Special Issue will publish full research articles and systematic reviews. Potential topics include, but are not limited to, the following research areas:
• cardiovascular imaging
• high blood pressure and cardiovascular disease
• cardiovascular tissue engineering
• meta‐analysis based on cardiovascular outcomes trials
• pathophysiology of chronic heart failure
• molecular genetics of cardiovascular disease: clinical implications
• cardiac arrhythmias
• biomarkers in Cardiovascular Medicine
It is my pleasure to invite you to submit manuscripts on the subject “State-of-the-Art Cardiovascular Medicine in Asia 2021” for this Special Issue. Full papers and communications, as well as comprehensive reviews, are welcome. Please feel free to contact me, the guest editor, in case of further questions.
Prof. Brian Tomlinson and Assoc. Prof. Takatoshi Kasai
Guest Editor
Keywords
- Cardiovascular anatomy
- Cardiac physiology
- Imaging techniques
- Cardiac regeneration
- Congenital heart disease
- Arrhythmias
- Animal models for cardiovascular diseases
- Genetics
- Blood pressure
- Biomarkers
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (47)
The Prevalence and Characteristics of Mitral Regurgitation in Heart Failure: A Chart Review Study
Rev. Cardiovasc. Med. 2022, 23(7), 235; https://doi.org/10.31083/j.rcm2307235
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Association between Triglycerides to High-Density Lipoprotein Cholesterol Ratio and Death Risk in Diabetic Patients with New-Onset Acute Coronary Syndrome: A Retrospective Cohort Study in the Han Chinese Population
Rev. Cardiovasc. Med. 2022, 23(6), 190; https://doi.org/10.31083/j.rcm2306190
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Coronary Artery Spasm: Risk Factors, Pathophysiological Mechanisms and Novel Diagnostic Approaches
Rev. Cardiovasc. Med. 2022, 23(5), 175; https://doi.org/10.31083/j.rcm2305175
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Clinical Features of Aortitis with Gastrointestinal Involvement
Rev. Cardiovasc. Med. 2022, 23(5), 162; https://doi.org/10.31083/j.rcm2305162
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Sleep Apnea and Abnormal Respiratory Patterns with Deep Sedation during Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation
Rev. Cardiovasc. Med. 2022, 23(4), 121; https://doi.org/10.31083/j.rcm2304121
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Elevated Serum Retinol Binding Protein 4 is Associated with the Risk of Diabetic Cardiomyopathy
Rev. Cardiovasc. Med. 2022, 23(4), 115; https://doi.org/10.31083/j.rcm2304115
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Natural History and Influence on Long-term Outcomes of Isolated Type II Endoleak after Endovascular Aneurysm Repair: A 10-year Experience at a Single Center
Rev. Cardiovasc. Med. 2022, 23(3), 99; https://doi.org/10.31083/j.rcm2303099
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
The Severity of Obstructive Sleep Apnea Increases the Risk of Arteriosclerosis
Rev. Cardiovasc. Med. 2022, 23(3), 94; https://doi.org/10.31083/j.rcm2303094
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Remifentanil versus Dexmedetomidine in Cardiac Surgery Patients with Noninvasive Ventilation Intolerance: Protocol for the REDNIVI Trial
Rev. Cardiovasc. Med. 2022, 23(3), 84; https://doi.org/10.31083/j.rcm2303084
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Preprocedural features of patients under antihypertensive drugs may help identify responders to renal denervation: a hypothesis-generating study
Rev. Cardiovasc. Med. 2022, 23(2), 65; https://doi.org/10.31083/j.rcm2302065
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Attitudes and behavioral intentions of aortic dissection survivors towards exercise: an application of the health action process approach framework
Rev. Cardiovasc. Med. 2022, 23(2), 64; https://doi.org/10.31083/j.rcm2302064
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives
Rev. Cardiovasc. Med. 2022, 23(2), 60; https://doi.org/10.31083/j.rcm2302060
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Comparison of diagnostic accuracy of immediate angiography derived residual quantitative flow ratio after bioresorbable scaffold and drug eluting stent implantation
Rev. Cardiovasc. Med. 2022, 23(2), 59; https://doi.org/10.31083/j.rcm2302059
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Construction of a pyroptosis-related classifier for risk prediction of acute myocardial infarction
Rev. Cardiovasc. Med. 2022, 23(2), 52; https://doi.org/10.31083/j.rcm2302052
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Mobilizing artificial intelligence to cardiac telerehabilitation
Rev. Cardiovasc. Med. 2022, 23(2), 45; https://doi.org/10.31083/j.rcm2302045
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment
Rev. Cardiovasc. Med. 2022, 23(1), 30; https://doi.org/10.31083/j.rcm2301030
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Comparison of NICE and ESC strategy for risk assessment in women with stable chest pain: a coronary computed tomography angiography study
Rev. Cardiovasc. Med. 2022, 23(1), 26; https://doi.org/10.31083/j.rcm2301026
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
Rev. Cardiovasc. Med. 2022, 23(1), 18; https://doi.org/10.31083/j.rcm2301018
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Genetic risk scores used in cardiovascular disease prediction models: a systematic review
Rev. Cardiovasc. Med. 2022, 23(1), 8; https://doi.org/10.31083/j.rcm2301008
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Impact of aortic atheroma and distensibility on diastolic function and prognosis in patients with ischemic stroke
Rev. Cardiovasc. Med. 2022, 23(1), 10; https://doi.org/10.31083/j.rcm2301010
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
The transition and outcomes of perioperative low ejection fraction status in cardiac surgical patients
Rev. Cardiovasc. Med. 2021, 22(4), 1721–1728; https://doi.org/10.31083/j.rcm2204180
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Relationship between non-culprit lesion plaque characteristics changes and in-stent neoatherosclerosis formation: 1-year follow-up optical coherence tomography study
Rev. Cardiovasc. Med. 2021, 22(4), 1693–1700; https://doi.org/10.31083/j.rcm2204177
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Non-ST elevation myocardial infarction in pregnancy—a critical review of current evidence and guidelines
Rev. Cardiovasc. Med. 2021, 22(4), 1535–1539; https://doi.org/10.31083/j.rcm2204157
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Effects of aerobic, resistance, and combined exercise on metabolic syndrome parameters and cardiovascular risk factors: a systematic review and network meta-analysis
Rev. Cardiovasc. Med. 2021, 22(4), 1523–1533; https://doi.org/10.31083/j.rcm2204156
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
The efficacy of trimetazidine in non-ischemic heart failure patients: a meta-analysis of randomized controlled trials
Rev. Cardiovasc. Med. 2021, 22(4), 1451–1459; https://doi.org/10.31083/j.rcm2204149
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
A narrative review of plant and herbal medicines for delaying diabetic atherosclerosis: an update and future perspectives
Rev. Cardiovasc. Med. 2021, 22(4), 1361–1381; https://doi.org/10.31083/j.rcm2204142
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome
Rev. Cardiovasc. Med. 2021, 22(4), 1295–1309; https://doi.org/10.31083/j.rcm2204136
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Atrial fibrillation in Middle Eastern Arabs and South Asians: a scoping review
Rev. Cardiovasc. Med. 2021, 22(4), 1185–1196; https://doi.org/10.31083/j.rcm2204127
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Validity of SOFA score as a prognostic tool for critically ill elderly patients with acute infective endocarditis
Rev. Cardiovasc. Med. 2021, 22(3), 967–973; https://doi.org/10.31083/j.rcm2203105
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Abnormal expression of TGFBR2, EGF, LRP10, and IQGAP1 is involved in the pathogenesis of coronary artery disease
Rev. Cardiovasc. Med. 2021, 22(3), 947–958; https://doi.org/10.31083/j.rcm2203103
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Comparison of standard versus modified stenting technique for treatment of tapered coronary artery lesions
Rev. Cardiovasc. Med. 2021, 22(3), 931–938; https://doi.org/10.31083/j.rcm2203101
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Association of polymorphisms in endothelial dysfunction-related genes with susceptibility to essential hypertension in elderly Han population in Liaoning province, China
Rev. Cardiovasc. Med. 2021, 22(3), 895–901; https://doi.org/10.31083/j.rcm2203096
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Effects of alirocumab on cardiovascular events and all-cause mortality: a systematic review and meta-analysis
Rev. Cardiovasc. Med. 2021, 22(3), 873–881; https://doi.org/10.31083/j.rcm2203093
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis
Rev. Cardiovasc. Med. 2021, 22(3), 865–872; https://doi.org/10.31083/j.rcm2203092
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Sudden cardiac death in patients with myocardial infarction: 1.5 primary prevention
Rev. Cardiovasc. Med. 2021, 22(3), 807–816; https://doi.org/10.31083/j.rcm2203087
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism
Rev. Cardiovasc. Med. 2021, 22(3), 769–777; https://doi.org/10.31083/j.rcm2203083
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
A scoping review of exercise-based cardiac rehabilitation for patients with aortic dissection
Rev. Cardiovasc. Med. 2021, 22(3), 613–624; https://doi.org/10.31083/j.rcm2203072
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
The ‘diamond’ approach to personalized drug treatment of heart failure with reduced ejection fraction
Rev. Cardiovasc. Med. 2021, 22(3), 573–584; https://doi.org/10.31083/j.rcm2203069
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Histone deacetylase inhibitor, mocetinostat, regulates cardiac remodelling and renin-angiotensin system activity in rats with transverse aortic constriction-induced pressure overload cardiac hypertrophy
Rev. Cardiovasc. Med. 2021, 22(3), 1037–1045; https://doi.org/10.31083/j.rcm2203113
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Endovascular repair of traumatic aortic dissection: a single-center experience
Rev. Cardiovasc. Med. 2021, 22(3), 1029–1035; https://doi.org/10.31083/j.rcm2203112
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Simulation of anticoagulation in atrial fibrillation patients with rivaroxaban—from trial to target population
Rev. Cardiovasc. Med. 2021, 22(3), 1019–1027; https://doi.org/10.31083/j.rcm2203111
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease
Rev. Cardiovasc. Med. 2021, 22(3), 1009–1017; https://doi.org/10.31083/j.rcm2203110
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Trends and distribution of coronary heart disease mortality rate in Hexi Corridor, Gansu, China from 2006 to 2015
Rev. Cardiovasc. Med. 2021, 22(3), 1003–1008; https://doi.org/10.31083/j.rcm2203109
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Lipocalin 2: could it be a new biomarker in pediatric pulmonary hypertension associated with congenital heart disease?
Rev. Cardiovasc. Med. 2021, 22(2), 531–536; https://doi.org/10.31083/j.rcm2202061
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Prevalence and treatment of high cardiovascular disease risk in Inner Mongolia, China
Rev. Cardiovasc. Med. 2021, 22(2), 521–529; https://doi.org/10.31083/j.rcm2202060
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
The pathomechanism of human myxomatous valvular degeneration at the mechanical and cellular level
Rev. Cardiovasc. Med. 2021, 22(2), 513–519; https://doi.org/10.31083/j.rcm2202059
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)
Hematocrit change as a predictor of readmission for decompensated heart failure: a retrospective single centre study
Rev. Cardiovasc. Med. 2021, 22(2), 505–512; https://doi.org/10.31083/j.rcm2202058
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in Asia 2021)